Skip to main content
Erschienen in: Radiation Oncology 1/2016

Open Access 01.12.2016 | Short report

Intra-fraction motion of the prostate is not increased by patient couch shifts

verfasst von: Hendrik Ballhausen, Ute Ganswindt, Claus Belka, Minglun Li

Erschienen in: Radiation Oncology | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

During a fraction of external beam radiotherapy for prostate cancer, a mismatch between target volume and dose coverage may accumulate over time due to intra-fraction motion. One way to remove the residual error is to perform a couch shift in opposite direction. In principle, such couch shifts could cause secondary displacements of the patient and prostate. Hence it is interesting to investigate if couch shifts might amplify intra-fraction motion.

Findings

Intra-fraction motion of the prostate and patient couch position were simultaneously recorded during 359 fractions in 15 patients. During this time, a total of 22 couch shifts of up to 31.5 mm along different axes were recorded. Prostate position and couch position were plotted before, during and after each couch shift. There was no visible impact of couch shifts on prostate motion. The standard deviation of prostate position was calculated before, during and after each couch shift. The standard deviation did not significantly increase during couch shifts (by 3 % on average, p = 0.88) and even slightly decreased after a couch shift (by 37 % on average; p = 0.02).

Conclusions

Shifts of the patient couch did not adversely affect the motion of the prostate relative to the patient couch. Hence, shifts of the patient couch may be a viable way to correct the position of the prostate relative to the dose distribution.
Hinweise

Competing interests

Elekta Germany supports research at the university hospitals of Ludwig-Maximilians-Universität, chair of professor Belka. Elekta supported various congress presentations by Prof. Claus Belka and Dr. Minglun Li. The other authors did not declare any conflict of interest.

Authors’ contributions

HB analyzed and interpreted the data and drafted the manuscript. ML supervised the acquisition of the data. UG and CB helped draft the manuscript. All authors have read and approved the manuscript.

Findings

Background

In external beam radiotherapy, tumor control probability and normal tissue toxicity [15] are strongly correlated to the ability to deposit dose within the limits of the clinical target volume. In case of the prostate, three-dimensional ultrasound is quite a precise image guidance modality both for patient positioning before each fraction [69] and for monitoring of the intra-fraction motion of the prostate [1012].
As the mismatch between target volume and dose coverage accumulates due to intra-fraction motion, one way to remove the residual error is to perform a couch shift in opposite direction. Ideally, the motion of the table (relative to the beam) translates into the exact same motion of the prostate (relative to the beam). However, in principle such couch shifts, due to accelerating forces, could cause secondary displacements of the patient and prostate (relative to the couch) or even aggravate intra-fraction motion. The aim of this study is to confirm or reject this possibility.

Patients and methods

Fifteen patients with histologically confirmed adenocarcinoma of the prostate were included in this analysis. All patients received norm-fractionated IMRT with 6 MV photons in our institution with a cumulative dose ranging from 70.0 to 76.0 Gy, depending on the tumor stage. Average age of patients was 72.0 ± 9.0 years (median 76.4 years, range 53.2 to 85.9 years).
Intra-fraction motion of the prostate was tracked during 359 fractions by four-dimensional perineal ultrasound. The Clarity ultrasound system (see Fig. 1) was used in combination with an auto-scanning perineal ultrasound probe [10] which provided estimates of the prostate position at a rate of about one to two Hertz. During this time, a total of 22 couch shifts of up to 31.5 mm along different axes were recorded.
For each couch shift, the (absolute) position of the couch and the position of the prostate (relative to the couch) were plotted for 3 min, centered on the shift. The plots were evaluated for any visible impact of couch movements on prostate motion relative to the couch.
Prostate motility was defined as the standard deviation of prostate positions. It was calculated for each 1 min before, during, and after each couch shift.

Results

The prostate position closely followed along the couch position in every case. Consider the example in Fig. 2. It was selected because of all recordings it features the largest amplitude of couch shifts. At 00:00, the prostate was off by 6.5 mm in absolute terms (relative to the beam isocenter), and the couch position was at zero (relative to the beam isocenter). Between 01:00 and 02:00 several couch shifts were performed, with a net offset of the couch of −6.5 mm (relative to the beam isocenter). The prostate closely followed all of these shifts (relative to the beam isocenter) such that there was no remaining residual error after the shifts, with the prostate at 0.0 mm after 02:00. During all of these shifts, the position of the prostate relative to the table continued its intra-fraction motion, however at much smaller amplitude and not visibly affected by even the largest shifts at a speed of 9.7 mm per second. Similar patterns of motion were observed during the 22 recorded couch shifts, all of which were plotted in Fig. 3. In no case there was any visible influence of the couch shifts (relative to the beam isocenter, red lines in Fig. 3) on intra-fraction motion of the prostate (relative to the couch, blue lines in Fig. 3).
The standard deviation of prostate positions (relative to the couch) as a measure of prostate motility was calculated for each of the 3 min shown in the plots. Average motility before the shifts was 0.26 mm ± 0.14 mm (mean ± SD, median 0.22 mm, range 0.08 to 0.61 mm); average motility during the shifts was 0.27 mm ± 0.16 mm (mean ± SD, median 0.22 mm, range 0.05 to 0.64 mm); average motility after the shifts was 0.17 mm ± 0.09 mm (mean ± SD, median 0.15 mm, range 0.06 to 0.51 mm); see Fig. 4.
Thus, motility did not significantly increase during couch shifts (by 3 % on average, p = 0.88) and even slightly decreased after a couch shift (by 37 % on average; p = 0.02). The decrease in motility after a couch shift could be a statistical artifact. Tentatively, it could be because patients tautened when experiencing couch shifts. In any case, this effect needs further measurements for confirmation and explanation.

Conclusions

Couch shifts for real time correction of intra-fractional setup errors did not result in any relevant secondary motion of the prostate. In particular, motility did not significantly increase during couch shifts.
In conclusion, the strategy of real time correction of intra-fractional setup errors seems feasible as far as our results with regard to possible secondary motion of the prostate are concerned.
Written informed consent was obtained from the patient for the publication of the accompanying image.

Acknowledgements

Funding for research with the Clarity system has been received from Elekta. Elekta was not involved in and had no influence on the study design, the collection, analysis or interpretation of data, on the writing of the manuscript or the decision to submit the manuscript for publication.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

Elekta Germany supports research at the university hospitals of Ludwig-Maximilians-Universität, chair of professor Belka. Elekta supported various congress presentations by Prof. Claus Belka and Dr. Minglun Li. The other authors did not declare any conflict of interest.

Authors’ contributions

HB analyzed and interpreted the data and drafted the manuscript. ML supervised the acquisition of the data. UG and CB helped draft the manuscript. All authors have read and approved the manuscript.
Literatur
1.
Zurück zum Zitat D’Avino V, Palma G, Liuzzi R, Conson M, Doria F, Salvatore M, et al. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer. Radiat Oncol. 2015;10:80.CrossRef D’Avino V, Palma G, Liuzzi R, Conson M, Doria F, Salvatore M, et al. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer. Radiat Oncol. 2015;10:80.CrossRef
2.
Zurück zum Zitat Sveistrup J, af Rosenschold PM, Deasy JO, Oh JH, Pommer T, Petersen PM, et al. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol. 2014;9:44.CrossRef Sveistrup J, af Rosenschold PM, Deasy JO, Oh JH, Pommer T, Petersen PM, et al. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol. 2014;9:44.CrossRef
3.
Zurück zum Zitat Valeriani M, Carnevale A, Osti MF, DE Sanctis V, Agolli L, Maurizi Enrici R. Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results. Radiat Oncol. 2014;9:214.CrossRef Valeriani M, Carnevale A, Osti MF, DE Sanctis V, Agolli L, Maurizi Enrici R. Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results. Radiat Oncol. 2014;9:214.CrossRef
4.
Zurück zum Zitat Yahya N, Ebert MA, Bulsara M, Haworth A, Kearvell R, Foo K, et al. Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial. Radiat Oncol. 2014;9:282.CrossRef Yahya N, Ebert MA, Bulsara M, Haworth A, Kearvell R, Foo K, et al. Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial. Radiat Oncol. 2014;9:282.CrossRef
5.
Zurück zum Zitat Zheng Y, Han F, Xiao W, Xiang Y, Lu L, Deng X, et al. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. Radiat Oncol. 2015;10:17.CrossRef Zheng Y, Han F, Xiao W, Xiang Y, Lu L, Deng X, et al. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. Radiat Oncol. 2015;10:17.CrossRef
6.
Zurück zum Zitat Ballhausen H, Ballhausen BD, Lachaine M, Li M, Parodi K, Belka C, et al. Surface refraction of sound waves affects calibration of three-dimensional ultrasound. Radiat Oncol. 2015;10:119.CrossRef Ballhausen H, Ballhausen BD, Lachaine M, Li M, Parodi K, Belka C, et al. Surface refraction of sound waves affects calibration of three-dimensional ultrasound. Radiat Oncol. 2015;10:119.CrossRef
7.
Zurück zum Zitat Ballhausen H, Hieber S, Li M, Belka C, Reiner M. Millimeter precision in ultrasound based patient positioning: Experimental quantification of inherent technical limitations. Med Phys. 2014;41:081718.CrossRef Ballhausen H, Hieber S, Li M, Belka C, Reiner M. Millimeter precision in ultrasound based patient positioning: Experimental quantification of inherent technical limitations. Med Phys. 2014;41:081718.CrossRef
8.
Zurück zum Zitat Ballhausen H, Hieber S, Li M, Parodi K, Belka C, Reiner M. Linearity of patient positioning detection : a phantom study of skin markers, cone beam computed tomography, and 3D ultrasound. Strahlenther Onkol. 2015;191:442–7.CrossRef Ballhausen H, Hieber S, Li M, Parodi K, Belka C, Reiner M. Linearity of patient positioning detection : a phantom study of skin markers, cone beam computed tomography, and 3D ultrasound. Strahlenther Onkol. 2015;191:442–7.CrossRef
9.
Zurück zum Zitat Li M, Ballhausen H, Hegemann NS, Ganswindt U, Manapov F, Tritschler S, et al. A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT. Radiat Oncol. 2015;10:82.CrossRef Li M, Ballhausen H, Hegemann NS, Ganswindt U, Manapov F, Tritschler S, et al. A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT. Radiat Oncol. 2015;10:82.CrossRef
10.
Zurück zum Zitat Lachaine M, Falco T. Intrafractional prostate motion management with the Clarity autoscan system. Med Phys Int. 2013;1:72–80. Lachaine M, Falco T. Intrafractional prostate motion management with the Clarity autoscan system. Med Phys Int. 2013;1:72–80.
11.
Zurück zum Zitat Ballhausen H, Li M, Hegemann NS, Ganswindt U, Belka C. Intra-fraction motion of the prostate is a random walk. Phys Med Biol. 2015;60:549–63.CrossRef Ballhausen H, Li M, Hegemann NS, Ganswindt U, Belka C. Intra-fraction motion of the prostate is a random walk. Phys Med Biol. 2015;60:549–63.CrossRef
12.
Zurück zum Zitat Ballhausen H, Reiner M, Kantz S, Belka C, Sohn M. The random walk model of intrafraction movement. Phys Med Biol. 2013;58:2413–27.CrossRef Ballhausen H, Reiner M, Kantz S, Belka C, Sohn M. The random walk model of intrafraction movement. Phys Med Biol. 2013;58:2413–27.CrossRef
Metadaten
Titel
Intra-fraction motion of the prostate is not increased by patient couch shifts
verfasst von
Hendrik Ballhausen
Ute Ganswindt
Claus Belka
Minglun Li
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
Radiation Oncology / Ausgabe 1/2016
Elektronische ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-016-0620-z

Weitere Artikel der Ausgabe 1/2016

Radiation Oncology 1/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.